This site is intended for healthcare professionals

Dupilumab and ocular adverse reactions: MHRA update

Posted 1 Mar 2024

Dr Anish Kotecha MRCGP FAcadMEd MBBCh BSc

Dr Anish Kotecha summarises an update from the MHRA regarding the risk of ocular adverse reactions with dupilumab and the need for prompt management.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page